Lawyers: CMS Effective Dates For Expanded Sunshine Reporting Unclear

October 10, 2018
Industry lawyers say it is not clear whether Congress' expansion of the sunshine law's reporting requirements to include industry payments to health professionals beyond doctors will kick in in 2021 or 2022. While the expansion, tucked into sweeping opioid legislation expected to be enacted soon, states that drug, device and biologic manufacturers' reporting of the new information will begin Jan. 1, 2022, it is not certain whether that means manufacturers should begin collecting data that day to fulfill the new...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.